Epigenetic mechanisms that underpin metabolic and cardiovascular diseases

An organism's ability to adjust its phenotypic development to the environment is partly determined by epigenetic changes that are established in early life and modulate gene expression during development and maturity. A mismatch between the inducing and the mature environment may result in inap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Endocrinology 2009-07, Vol.5 (7), p.401-408
Hauptverfasser: Gluckman, Peter D, Hanson, Mark A, Buklijas, Tatjana, Low, Felicia M, Beedle, Alan S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 408
container_issue 7
container_start_page 401
container_title Nature reviews. Endocrinology
container_volume 5
creator Gluckman, Peter D
Hanson, Mark A
Buklijas, Tatjana
Low, Felicia M
Beedle, Alan S
description An organism's ability to adjust its phenotypic development to the environment is partly determined by epigenetic changes that are established in early life and modulate gene expression during development and maturity. A mismatch between the inducing and the mature environment may result in inappropriate patterns of epigenetic marks and of gene expression that increase the organism's susceptibility to chronic noncommunicable disease. The authors review the relationships between environmental influences during mammalian development, epigenetic changes and metabolic and cardiovascular diseases, and discuss the implications for prevention and treatment. Cellular commitment to a specific lineage is controlled by differential silencing of genes, which in turn depends on epigenetic processes such as DNA methylation and histone modification. During early embryogenesis, the mammalian genome is 'wiped clean' of most epigenetic modifications, which are progressively re-established during embryonic development. Thus, the epigenome of each mature cellular lineage carries the record of its developmental history. The subsequent trajectory and pattern of development are also responsive to environmental influences, and such plasticity is likely to have an epigenetic basis. Epigenetic marks may be transmitted across generations, either directly by persisting through meiosis or indirectly through replication in the next generation of the conditions in which the epigenetic change occurred. Developmental plasticity evolved to match an organism to its environment, and a mismatch between the phenotypic outcome of adaptive plasticity and the current environment increases the risk of metabolic and cardiovascular disease. These considerations point to epigenetic processes as a key mechanism that underpins the developmental origins of chronic noncommunicable disease. Here, we review the evidence that environmental influences during mammalian development lead to stable changes in the epigenome that alter the individual's susceptibility to chronic metabolic and cardiovascular disease, and discuss the clinical implications. Key Points Developmental plasticity enables an organism to respond to environmental cues and adjust its phenotypic development to match its environment Developmental plasticity is effected, at least in part, by epigenetic changes that are established in early life and modulate gene expression during development and maturity In mammals, the window during which the ep
doi_str_mv 10.1038/nrendo.2009.102
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_67404865</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A202797582</galeid><sourcerecordid>A202797582</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-1752721d9600407711bb3c00edba5fe72a4897d90c199c848b0d1d38338a4dd93</originalsourceid><addsrcrecordid>eNp1kc9rFDEUxwdRbK2evcmA6G23L5lMfhxLqVooeNFzyCRvdlNmkjXJCP73Zp2l1YLkkPDe5_t9L3yb5i2BLYFOXoaEwcUtBVC1QJ8150T0atNDJ54_vKk6a17lfA_AORPsZXNGFJMSRH_e3N4c_A4DFm_bGe3eBJ_n3Ja9Ke0SHKaDD7VRzBCnipjgWmuS8_GnyXaZTGqdz2gy5tfNi9FMGd-c7ovm-6ebb9dfNndfP99eX91tLOOsbOpOVFDiFAdgIAQhw9BZAHSD6UcU1DCphFNgiVJWMjmAI66TXScNc051F83H1feQ4o8Fc9GzzxanyQSMS9ZcMGCS9xV8_wS8j0sKdTdNhBSUK97xSm1Xamcm1D6MsSRj63E4exsDjr7WryhQoUQv6eP8P4I9mqnsc5yW4mPI_4KXK2hTzDnhqA_Jzyb90gT0MT29pqeP6dXCUfHutPEyzOge-VNcFYAVyLUVdpj--tJ_PT-skmDKkvDB8yn3G1-bse4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1787269636</pqid></control><display><type>article</type><title>Epigenetic mechanisms that underpin metabolic and cardiovascular diseases</title><source>MEDLINE</source><source>Nature Journals Online</source><source>SpringerLink Journals - AutoHoldings</source><creator>Gluckman, Peter D ; Hanson, Mark A ; Buklijas, Tatjana ; Low, Felicia M ; Beedle, Alan S</creator><creatorcontrib>Gluckman, Peter D ; Hanson, Mark A ; Buklijas, Tatjana ; Low, Felicia M ; Beedle, Alan S</creatorcontrib><description>An organism's ability to adjust its phenotypic development to the environment is partly determined by epigenetic changes that are established in early life and modulate gene expression during development and maturity. A mismatch between the inducing and the mature environment may result in inappropriate patterns of epigenetic marks and of gene expression that increase the organism's susceptibility to chronic noncommunicable disease. The authors review the relationships between environmental influences during mammalian development, epigenetic changes and metabolic and cardiovascular diseases, and discuss the implications for prevention and treatment. Cellular commitment to a specific lineage is controlled by differential silencing of genes, which in turn depends on epigenetic processes such as DNA methylation and histone modification. During early embryogenesis, the mammalian genome is 'wiped clean' of most epigenetic modifications, which are progressively re-established during embryonic development. Thus, the epigenome of each mature cellular lineage carries the record of its developmental history. The subsequent trajectory and pattern of development are also responsive to environmental influences, and such plasticity is likely to have an epigenetic basis. Epigenetic marks may be transmitted across generations, either directly by persisting through meiosis or indirectly through replication in the next generation of the conditions in which the epigenetic change occurred. Developmental plasticity evolved to match an organism to its environment, and a mismatch between the phenotypic outcome of adaptive plasticity and the current environment increases the risk of metabolic and cardiovascular disease. These considerations point to epigenetic processes as a key mechanism that underpins the developmental origins of chronic noncommunicable disease. Here, we review the evidence that environmental influences during mammalian development lead to stable changes in the epigenome that alter the individual's susceptibility to chronic metabolic and cardiovascular disease, and discuss the clinical implications. Key Points Developmental plasticity enables an organism to respond to environmental cues and adjust its phenotypic development to match its environment Developmental plasticity is effected, at least in part, by epigenetic changes that are established in early life and modulate gene expression during development and maturity In mammals, the window during which the epigenome is susceptible to nutritional cues extends from conception to at least weaning Mismatch between the early and mature environments may result in inappropriate patterns of epigenetic changes and gene expression that increase subsequent susceptibility to metabolic and cardiovascular diseases The available evidence suggests that interventions to prevent metabolic and cardiovascular diseases should focus on the prenatal and early postnatal periods</description><identifier>ISSN: 1759-5029</identifier><identifier>EISSN: 1759-5037</identifier><identifier>DOI: 10.1038/nrendo.2009.102</identifier><identifier>PMID: 19488075</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Accreditation ; Animals ; Birth weight ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - genetics ; Diabetes ; DNA methylation ; Endocrinology ; Epigenesis, Genetic - genetics ; Epigenesis, Genetic - physiology ; Epigenetic inheritance ; Epigenetics ; Gene expression ; Genetic aspects ; Genomes ; Humans ; Medical education ; Medicine ; Medicine &amp; Public Health ; Metabolic diseases ; Metabolic Diseases - etiology ; Metabolic Diseases - genetics ; Metabolism ; Nutrition ; review-article ; Risk factors</subject><ispartof>Nature reviews. Endocrinology, 2009-07, Vol.5 (7), p.401-408</ispartof><rights>Springer Nature Limited 2009</rights><rights>COPYRIGHT 2009 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jul 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-1752721d9600407711bb3c00edba5fe72a4897d90c199c848b0d1d38338a4dd93</citedby><cites>FETCH-LOGICAL-c464t-1752721d9600407711bb3c00edba5fe72a4897d90c199c848b0d1d38338a4dd93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nrendo.2009.102$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nrendo.2009.102$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27915,27916,41479,42548,51310</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19488075$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gluckman, Peter D</creatorcontrib><creatorcontrib>Hanson, Mark A</creatorcontrib><creatorcontrib>Buklijas, Tatjana</creatorcontrib><creatorcontrib>Low, Felicia M</creatorcontrib><creatorcontrib>Beedle, Alan S</creatorcontrib><title>Epigenetic mechanisms that underpin metabolic and cardiovascular diseases</title><title>Nature reviews. Endocrinology</title><addtitle>Nat Rev Endocrinol</addtitle><addtitle>Nat Rev Endocrinol</addtitle><description>An organism's ability to adjust its phenotypic development to the environment is partly determined by epigenetic changes that are established in early life and modulate gene expression during development and maturity. A mismatch between the inducing and the mature environment may result in inappropriate patterns of epigenetic marks and of gene expression that increase the organism's susceptibility to chronic noncommunicable disease. The authors review the relationships between environmental influences during mammalian development, epigenetic changes and metabolic and cardiovascular diseases, and discuss the implications for prevention and treatment. Cellular commitment to a specific lineage is controlled by differential silencing of genes, which in turn depends on epigenetic processes such as DNA methylation and histone modification. During early embryogenesis, the mammalian genome is 'wiped clean' of most epigenetic modifications, which are progressively re-established during embryonic development. Thus, the epigenome of each mature cellular lineage carries the record of its developmental history. The subsequent trajectory and pattern of development are also responsive to environmental influences, and such plasticity is likely to have an epigenetic basis. Epigenetic marks may be transmitted across generations, either directly by persisting through meiosis or indirectly through replication in the next generation of the conditions in which the epigenetic change occurred. Developmental plasticity evolved to match an organism to its environment, and a mismatch between the phenotypic outcome of adaptive plasticity and the current environment increases the risk of metabolic and cardiovascular disease. These considerations point to epigenetic processes as a key mechanism that underpins the developmental origins of chronic noncommunicable disease. Here, we review the evidence that environmental influences during mammalian development lead to stable changes in the epigenome that alter the individual's susceptibility to chronic metabolic and cardiovascular disease, and discuss the clinical implications. Key Points Developmental plasticity enables an organism to respond to environmental cues and adjust its phenotypic development to match its environment Developmental plasticity is effected, at least in part, by epigenetic changes that are established in early life and modulate gene expression during development and maturity In mammals, the window during which the epigenome is susceptible to nutritional cues extends from conception to at least weaning Mismatch between the early and mature environments may result in inappropriate patterns of epigenetic changes and gene expression that increase subsequent susceptibility to metabolic and cardiovascular diseases The available evidence suggests that interventions to prevent metabolic and cardiovascular diseases should focus on the prenatal and early postnatal periods</description><subject>Accreditation</subject><subject>Animals</subject><subject>Birth weight</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - genetics</subject><subject>Diabetes</subject><subject>DNA methylation</subject><subject>Endocrinology</subject><subject>Epigenesis, Genetic - genetics</subject><subject>Epigenesis, Genetic - physiology</subject><subject>Epigenetic inheritance</subject><subject>Epigenetics</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Genomes</subject><subject>Humans</subject><subject>Medical education</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic diseases</subject><subject>Metabolic Diseases - etiology</subject><subject>Metabolic Diseases - genetics</subject><subject>Metabolism</subject><subject>Nutrition</subject><subject>review-article</subject><subject>Risk factors</subject><issn>1759-5029</issn><issn>1759-5037</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kc9rFDEUxwdRbK2evcmA6G23L5lMfhxLqVooeNFzyCRvdlNmkjXJCP73Zp2l1YLkkPDe5_t9L3yb5i2BLYFOXoaEwcUtBVC1QJ8150T0atNDJ54_vKk6a17lfA_AORPsZXNGFJMSRH_e3N4c_A4DFm_bGe3eBJ_n3Ja9Ke0SHKaDD7VRzBCnipjgWmuS8_GnyXaZTGqdz2gy5tfNi9FMGd-c7ovm-6ebb9dfNndfP99eX91tLOOsbOpOVFDiFAdgIAQhw9BZAHSD6UcU1DCphFNgiVJWMjmAI66TXScNc051F83H1feQ4o8Fc9GzzxanyQSMS9ZcMGCS9xV8_wS8j0sKdTdNhBSUK97xSm1Xamcm1D6MsSRj63E4exsDjr7WryhQoUQv6eP8P4I9mqnsc5yW4mPI_4KXK2hTzDnhqA_Jzyb90gT0MT29pqeP6dXCUfHutPEyzOge-VNcFYAVyLUVdpj--tJ_PT-skmDKkvDB8yn3G1-bse4</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Gluckman, Peter D</creator><creator>Hanson, Mark A</creator><creator>Buklijas, Tatjana</creator><creator>Low, Felicia M</creator><creator>Beedle, Alan S</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20090701</creationdate><title>Epigenetic mechanisms that underpin metabolic and cardiovascular diseases</title><author>Gluckman, Peter D ; Hanson, Mark A ; Buklijas, Tatjana ; Low, Felicia M ; Beedle, Alan S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-1752721d9600407711bb3c00edba5fe72a4897d90c199c848b0d1d38338a4dd93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Accreditation</topic><topic>Animals</topic><topic>Birth weight</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - genetics</topic><topic>Diabetes</topic><topic>DNA methylation</topic><topic>Endocrinology</topic><topic>Epigenesis, Genetic - genetics</topic><topic>Epigenesis, Genetic - physiology</topic><topic>Epigenetic inheritance</topic><topic>Epigenetics</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Genomes</topic><topic>Humans</topic><topic>Medical education</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic diseases</topic><topic>Metabolic Diseases - etiology</topic><topic>Metabolic Diseases - genetics</topic><topic>Metabolism</topic><topic>Nutrition</topic><topic>review-article</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gluckman, Peter D</creatorcontrib><creatorcontrib>Hanson, Mark A</creatorcontrib><creatorcontrib>Buklijas, Tatjana</creatorcontrib><creatorcontrib>Low, Felicia M</creatorcontrib><creatorcontrib>Beedle, Alan S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gluckman, Peter D</au><au>Hanson, Mark A</au><au>Buklijas, Tatjana</au><au>Low, Felicia M</au><au>Beedle, Alan S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epigenetic mechanisms that underpin metabolic and cardiovascular diseases</atitle><jtitle>Nature reviews. Endocrinology</jtitle><stitle>Nat Rev Endocrinol</stitle><addtitle>Nat Rev Endocrinol</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>5</volume><issue>7</issue><spage>401</spage><epage>408</epage><pages>401-408</pages><issn>1759-5029</issn><eissn>1759-5037</eissn><abstract>An organism's ability to adjust its phenotypic development to the environment is partly determined by epigenetic changes that are established in early life and modulate gene expression during development and maturity. A mismatch between the inducing and the mature environment may result in inappropriate patterns of epigenetic marks and of gene expression that increase the organism's susceptibility to chronic noncommunicable disease. The authors review the relationships between environmental influences during mammalian development, epigenetic changes and metabolic and cardiovascular diseases, and discuss the implications for prevention and treatment. Cellular commitment to a specific lineage is controlled by differential silencing of genes, which in turn depends on epigenetic processes such as DNA methylation and histone modification. During early embryogenesis, the mammalian genome is 'wiped clean' of most epigenetic modifications, which are progressively re-established during embryonic development. Thus, the epigenome of each mature cellular lineage carries the record of its developmental history. The subsequent trajectory and pattern of development are also responsive to environmental influences, and such plasticity is likely to have an epigenetic basis. Epigenetic marks may be transmitted across generations, either directly by persisting through meiosis or indirectly through replication in the next generation of the conditions in which the epigenetic change occurred. Developmental plasticity evolved to match an organism to its environment, and a mismatch between the phenotypic outcome of adaptive plasticity and the current environment increases the risk of metabolic and cardiovascular disease. These considerations point to epigenetic processes as a key mechanism that underpins the developmental origins of chronic noncommunicable disease. Here, we review the evidence that environmental influences during mammalian development lead to stable changes in the epigenome that alter the individual's susceptibility to chronic metabolic and cardiovascular disease, and discuss the clinical implications. Key Points Developmental plasticity enables an organism to respond to environmental cues and adjust its phenotypic development to match its environment Developmental plasticity is effected, at least in part, by epigenetic changes that are established in early life and modulate gene expression during development and maturity In mammals, the window during which the epigenome is susceptible to nutritional cues extends from conception to at least weaning Mismatch between the early and mature environments may result in inappropriate patterns of epigenetic changes and gene expression that increase subsequent susceptibility to metabolic and cardiovascular diseases The available evidence suggests that interventions to prevent metabolic and cardiovascular diseases should focus on the prenatal and early postnatal periods</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>19488075</pmid><doi>10.1038/nrendo.2009.102</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1759-5029
ispartof Nature reviews. Endocrinology, 2009-07, Vol.5 (7), p.401-408
issn 1759-5029
1759-5037
language eng
recordid cdi_proquest_miscellaneous_67404865
source MEDLINE; Nature Journals Online; SpringerLink Journals - AutoHoldings
subjects Accreditation
Animals
Birth weight
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - etiology
Cardiovascular Diseases - genetics
Diabetes
DNA methylation
Endocrinology
Epigenesis, Genetic - genetics
Epigenesis, Genetic - physiology
Epigenetic inheritance
Epigenetics
Gene expression
Genetic aspects
Genomes
Humans
Medical education
Medicine
Medicine & Public Health
Metabolic diseases
Metabolic Diseases - etiology
Metabolic Diseases - genetics
Metabolism
Nutrition
review-article
Risk factors
title Epigenetic mechanisms that underpin metabolic and cardiovascular diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T02%3A03%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epigenetic%20mechanisms%20that%20underpin%20metabolic%20and%20cardiovascular%20diseases&rft.jtitle=Nature%20reviews.%20Endocrinology&rft.au=Gluckman,%20Peter%20D&rft.date=2009-07-01&rft.volume=5&rft.issue=7&rft.spage=401&rft.epage=408&rft.pages=401-408&rft.issn=1759-5029&rft.eissn=1759-5037&rft_id=info:doi/10.1038/nrendo.2009.102&rft_dat=%3Cgale_proqu%3EA202797582%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1787269636&rft_id=info:pmid/19488075&rft_galeid=A202797582&rfr_iscdi=true